Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
38.41
-0.34 (-0.88%)
Aug 7, 2026, 4:00 PM EDT - Market closed
HRMY Market Cap
HRMY has a market cap or net worth of $2.24 billion as of August 7, 2026. Its market cap has increased by 12.14% in one year.
Market Cap
2.24B
Enterprise Value
1.73B
1-Year Change
12.14%
Ranking
Category
Stock Price
$38.41
ChartMarket Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $461.03M to $2.24B, an increase of 385.18%. That is a compound annual growth rate of 30.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 2.24B | 3.79% |
| Dec 31, 2025 | 2.16B | 9.82% |
| Dec 31, 2024 | 1.96B | 3.73% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SELLAS Life Sciences Group | 2.36B |
| Vera Therapeutics | 2.36B |
| Hemab Therapeutics Holdings | 2.32B |
| Nuvation Bio | 2.32B |
| Vericel | 2.31B |
| Sionna Therapeutics | 2.31B |
| UroGen Pharma | 2.30B |
| Palvella Therapeutics | 2.27B |